Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05479812 |
Title | Dose Escalation Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Werewolf Therapeutics, Inc. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
HonorHealth | RECRUITING | Scottsdale | Arizona | 85258 | United States | Details |
Emory Winship Cancer Institute | RECRUITING | Atlanta | Georgia | 30322 | United States | Details |
Northwestern University | RECRUITING | Chicago | Illinois | 60611 | United States | Details |
Indiana University Melvin and Bren Simon Comprehensive Cancer Center | RECRUITING | Indianapolis | Indiana | 46202 | United States | Details |
Roswell Park Comprehensive Cancer Care | RECRUITING | Buffalo | New York | 14203 | United States | Details |
Westchester Medical Center | COMPLETED | Hawthorne | New York | 10532 | United States | Details |
Providence Cancer Institute Franz Clinic | RECRUITING | Portland | Oregon | 97213 | United States | Details |
NEXT Oncology | RECRUITING | San Antonio | Texas | 78229 | United States | Details |